ADC Therapeutics SA (ADCT) Earnings Date & Reports
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ADCT is expected to report earnings to rise 81.82% to -40 cents per share on August 12
Q2'25
Est.
$-0.40
Q1'25
Beat
by $0.18
Q4'24
Beat
by $0.18
Q3'24
Beat
by $0.10
Q2'24
Beat
by $0.08
The last earnings report on May 14 showed earnings per share of -21 cents, beating the estimate of -40 cents. With 637.35K shares outstanding, the current market capitalization sits at 341.17M.